-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hydroxyurea in Sickle Cell Disease

Program: Special-Interest Sessions
Session: Special Symposium on Quality - Identifying and Addressing Underuse in Hematologic Care
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI) , Hemoglobinopathies, Diseases, Therapies
Saturday, December 9, 2023, 2:00 PM-3:30 PM

Alexandra Power-Hays, MD

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

Disclosures: No relevant conflicts of interest to declare.